CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GSK plc

GSK
$101.68B
Large Cap
NYSEPharmaceutical PreparationsPharmaceuticals🇺🇸EuropeLONDON65.0K employees

GSK plc (an abbreviation of its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.

Website

Drugs in Pipeline

503

Phase 3 Programs

265

Upcoming Catalysts

13

Next Catalyst

This month

Market Overview

Stock performance and key metrics

GSK News
Catalyst Timeline

15 upcoming, 3 past

Phase 2Next

Flu mRNA (Formulation B1) Phase 2 Est. Readout

September 2026~STALE+IMMINENTFlu mRNA (Formulation B1)960

Primary completion for Flu mRNA (Formulation B1) trial (NCT07204964) in Influenza, Human

Source

14 more catalysts beyond 14 days

Start a 48-hour free trial to see all upcoming catalysts

Pro

How GSK's past catalysts played out

PDUFA decisionJun 2019+3%
Drug Pipeline

Daprodustat small

Phase 3

Anaemia

FF/VI

Phase 3

Pulmonary Disease, Chronic Obstructive

Depemokimab (GSK3511294)

Phase 3

Nasal Polyps

Pneumococcal conjugate vaccine GSK1024850A

Phase 3

Infections, Streptococcal

Mencevax™ ACWY

Phase 3

Infections, Meningococcal

Influsplit™ Tetra (Fluarix™ Tetra)

Phase 3

Influenza

Fluarix Quadrivalent

Phase 3

Influenza

Umeclidinium bromide

Phase 3

Pulmonary Disease, Chronic Obstructive

Havrix®

Phase 3

Hepatitis A

323U66 (Bupropion Hydrochloride Sustained Release)

Phase 3

Depressive Disorder

Engerix™-B (thiomersal-free) 20µg

Phase 3

Hepatitis B

valaciclovir HCl granules

Phase 3

Varicella

Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ)

Phase 3

Infections, Meningococcal

Tritanrix-HepB/Hib-MenAC

Phase 3

Whole Cell Pertussis

HBV-MPL 208129

Phase 3

Hepatitis B

Chemotherapy

Phase 3

Melanoma

GSK 573719 +GW642444 125/25

Phase 3

Pulmonary Disease, Chronic Obstructive

GSK1562902A

Phase 3

Influenza

Priorix

Phase 3

Measles; Mumps; Rubella

GSK3511294 (Depemokimab)

Phase 3

Asthma

fondaparinux - UFH not indicated

Phase 3

Thromboembolism

Sumatriptan 25 mg

Phase 3

Migraine Disorders

GW572016 (Lapatinib)

Phase 3

Neoplasms, Breast

Havrix™

Phase 3

Hepatitis A

0.254% w/w sodium fluoride and 5% KNO3

Phase 3

Tooth Erosion

Combined diphtheria, tetanus, acellular pertussis vaccine

Phase 3

Diphtheria

Linerixibat

Phase 3

Pruritus

PCV20

Phase 3

Respiratory Syncytial Virus Infections

GSK Biologicals' candidate Plasmodium falciparum malaria vaccine (257049)

Phase 3

Malaria

LAMICTAL extended-release

Phase 3

Epilepsy

GSK573719/GW642444 Inhalation Powder

Phase 3

Pulmonary Disease, Chronic Obstructive

Twinrix ™ Paediatric

Phase 3

Infections, Papillomavirus

darapladib

Phase 3

Retinopathy, Diabetic

GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM)

Phase 3

Infections, Papillomavirus

MenitorixTM

Phase 3

Neisseria Meningitidis

Mepolizumab 300 mg

Phase 3

Hypereosinophilic Syndrome

Boostrix

Phase 3

Tetanus

Retigabine IR

Phase 3

Epilepsy

Insulin Glargine and Insulin Lispro

Phase 3

Diabetes Mellitus, Type 2

Herpes simplex candidate vaccine- adjuvanted GSK 208141

Phase 3

Prophylaxis for Herpes Simplex

Fondaparinux sodium

Phase 3

Embolism, Pulmonary

Danazol

Phase 3

Primary Myelofibrosis

GSK Biologicals' HPV vaccine 580299

Phase 3

Infections, Papillomavirus

Influsplit Tetra™ vaccine produced by investigational process (IP)

Phase 3

Influenza

2-dose oral live attenuated G1P[8] human rotavirus vaccine

Phase 3

Infections, Rotavirus

Ezogabine: USAN Retigabine (International Nonproprietary Name)

Phase 3

Epilepsy

Mepolizumab 100mg

Phase 3

Asthma

DTPw-HBV/Hib Kft vaccine GSK323527A

Phase 3

Hepatitis B

Rosiglitazone

Phase 3

Diabetes Mellitus, Type 2

GSK573719/GW642444 62.5/25

Phase 3

Pulmonary Disease, Chronic Obstructive

Intravenous (IV) zanamivir

Phase 3

Influenza, Human

LEXIVA (GW433908)

Phase 3

HIV Infection

mometasone furoate

Phase 3

Rhinitis, Allergic, Perennial

Dutasteride 0.5 mg

Phase 3

Alopecia

Influenza vaccine GSK2321138A

Phase 3

Influenza

Pneumococcal conjugate vaccine GSK1024850A.

Phase 3

Infections, Streptococcal

mRNA-1273

Phase 3

Herpes Zoster

HSV vaccine or SB208141, GSK Biologicals' glycoprotein D (gD)-Alum/3-deacylated form of Monophosphoryl Lipid A (MPL) candidate genital herpes vaccine

Phase 3

Herpes Simplex Infection

PoliorixTM

Phase 3

Poliomyelitis

Nitrofurantoin

Phase 3

Urinary Tract Infections

GSK573719/GW642444 125/25mcg

Phase 3

Pulmonary Disease, Chronic Obstructive

Ropinirole

Phase 3

Restless Legs Syndrome

Itraconazole 100mg capsules

Phase 3

Onychomycosis

alitretinoin

Phase 3

Eczema

CTGel/ BPO Wash

Phase 3

Acne Vulgaris

CAPEOX

Phase 3

Colonic Neoplasms

Momelotinib

Phase 3

Primary Myelofibrosis

GW815SF HFA MDI

Phase 3

Bronchial Asthma

Vilanterol

Phase 3

Asthma

Liarozole

Phase 3

Ichthyosis, Lamellar

Sodium Monofluorophosphate

Phase 3

Dentine Hypersensitivity

Meningococcal vaccine GSK134612

Phase 3

Infections, Meningococcal

NC-503 (Anti-amyloidotic (AA) Agent)

Phase 3

Secondary (AA) Amyloidosis

HBV-MPL vaccine 208129

Phase 3

Hepatitis B

clindamycin / benzoyl peroxide gel

Phase 3

Acne Vulgaris

Umeclidinium

Phase 3

Hyperhidrosis

Paracetamol 1000 mg SR tablets

Phase 3

Pain

U0267

Phase 3

Psoriasis

Calcipotriene Foam

Phase 3

Psoriasis

GlaxoSmithKline (GSK) Biologicals' candidate Plasmodium falciparum malaria vaccine 257049

Phase 3

Malaria

sodium fluoride

Phase 3

Enamel Erosion

BLU-5937

Phase 3

Cough

Tazarotene foam

Phase 3

Acne Vulgaris

CT Gel

Phase 3

Acne Vulgaris

GW685698X

Phase 3

Asthma

Retpamulin Ointment, 1%

Phase 3

Skin Infections, Bacterial

Best Available Therapy (BAT)

Phase 3

Primary Myelofibrosis (PMF)

Botulinum toxin A (GSK1358820)

Phase 3

Spasticity, Post-Stroke

Haemophilus influenzae type b and meningococcal serogroup C (vaccine)

Phase 3

Haemophilus Influenzae Type b

Dutasteride

Phase 3

Alopecia

U0267 Foam

Phase 3

Psoriasis

Combination Tablet of Treximet (sumatriptan/naproxen sodium)

Phase 3

Migraine Disorders

SB-275833 ointment, 1%

Phase 3

Impetigo

Rotarix (primary vaccination study)

Phase 3

Infections, Rotavirus

Tritanrix™- HepB

Phase 3

Infections, Meningococcal

Herpes Zoster vaccine GSK 1437173A

Phase 3

Herpes Zoster

denosumab

Phase 3

Osteoporosis, Postmenopausal

Niraparib

Phase 3

Ovarian Neoplasms

AAAA

Phase 3

Chronic Hepatitis B

Lamivudine plus Polyethylene glyco-interferon alfa-2b

Phase 3

Chronic Hepatitis B

Sodium Fluoride Toothpaste

Phase 3

Caries

Infanrix+Hib™

Phase 3

Acellular Pertussis

GSK3511294

Phase 3

Asthma

sumatriptan succinate/naproxen sodium

Phase 3

Migraine

Sumatriptan and Naproxen Sodium

Phase 3

Migraine Disorders

ropinirole controlled-release (REQUIP CR) for RLS

Phase 3

Parkinson's Disease

Cervarix TM

Phase 3

Infections, Papillomavirus

fosamprenavir

Phase 3

HIV Infections

GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108)

Phase 3

Haemophilus Influenzae Type b

ropinirole Extended Release (XR)

Phase 3

Restless Legs Syndrome

HPV-16/18 L1/AS04

Phase 3

Infections, Papillomavirus

Pneumococcal vaccine GSK1024850A

Phase 3

Infections, Streptococcal

Otelixizumab

Phase 3

Diabetes Mellitus, Type 1

Quadrivalent influenza GSK2282512A vaccine

Phase 3

Influenza

Experimental Denture Adhesive

Phase 3

Denture Retention

lamotrigine extended-release

Phase 3

Epilepsy

GSK1120212

Phase 3

Cancer

H5N1 adjuvanted split virus vaccine (A/Vietnam/1194/2004 strain)

Phase 3

Influenza

Depemokimab

Phase 3

Pulmonary Disease, Chronic Obstructive

Cervarix

Phase 3

Human Papillomavirus (HPV) Infection

Pneumococcal (vaccine)

Phase 3

Acellular Pertussis

GSK investigational vaccine GSK2340272A

Phase 3

Influenza

SB213503 lot 1

Phase 3

Tetanus

GSK1325760A

Phase 3

Pulmonary Arterial Hypertension

Thiomersal free trivalent influenza split vaccine 2003/2004

Phase 3

Influenza

Casopitant (GW679769) oral tablets

Phase 3

Vomiting

Netivudine

Phase 3

HIV Infections

Engerix™-B

Phase 3

Hepatitis B

GW685698X Aqueous Nasal Spray

Phase 3

Rhinitis, Allergic, Seasonal

Efimosfermin alfa

Phase 3

Non-alcoholic Fatty Liver Disease

Abacavir sulfate

Phase 3

HIV Infections

FSC

Phase 3

Pulmonary Disease, Chronic Obstructive

Botulinum Toxin Type A

Phase 3

Glabellar Lines

Lamivudine

Phase 3

HIV Infections

Pentamidine isethionate

Phase 3

Pneumonia, Pneumocystis Carinii

Fluviral®

Phase 3

Influenza

HRV Liquid

Phase 3

Rotavirus

Lamivudine/Zidovudine

Phase 3

HIV Infections

Zidovudine

Phase 3

HIV Infections

Atovaquone

Phase 3

Pneumonia, Pneumocystis Carinii

Dutasteride 0.5mg capsule

Phase 3

Benign Prostatic Hyperplasia

albiglutide

Phase 3

Diabetes Mellitus, Type 2

Amprenavir

Phase 3

HIV Infections

Gepotidacin

Phase 3

Infections, Bacterial

Lovaza (omega-3-acid ethyl esters) [formerly known as Omacor] plus atorvastatin

Phase 3

Hypertriglyceridemia

Indinavir sulfate

Phase 3

HIV Infections

GSK1278863

Phase 3

Anaemia

Levocetirizine

Phase 3

Rhinitis

Ropinirole XL (formerly CR)

Phase 3

Parkinson Disease

GSK1358820

Phase 3

Urinary Bladder, Overactive

FF/GW642444 Inhalation Powder

Phase 3

Pulmonary Disease, Chronic Obstructive

GSK investigational vaccine GSK1557482A

Phase 3

Influenza

Casopitant

Phase 3

Nausea and Vomiting, Chemotherapy-Induced

fondaparinux

Phase 3

Fibrillation, Atrial

Cervarix™ (HPV-16/18 L1 VLP AS04)

Phase 3

Infections, Papillomavirus

ropinirole PR/XR

Phase 3

Parkinson Disease

Standard therapy (Including Immunosuppressants)

Phase 3

Systemic Lupus Erythematosus

GSK Biologicals' combined diphtheria, tetanus, acellular pertussis vaccine

Phase 3

Diphtheria

Fluarix/Influsplit SSW 2012-2013

Phase 3

Influenza

Rotarix

Phase 3

Infections, Rotavirus

human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine

Phase 3

Cervical Cancer

Subjects received 3 doses of GSK Biologicals' HPV vaccine (580299) (Cervarix™)

Phase 3

Infections, Papillomavirus

lamotrigine

Phase 3

Schizophrenia

paroxetine

Phase 3

Social Anxiety Disorder

Retosiban

Phase 3

Obstetric Labour, Premature

MMRV

Phase 3

Rubella

Twinrix™ adult

Phase 3

Hepatitis B

FF/VI via ELLIPTA DPI

Phase 3

Asthma

GW642444 Inhalation Powder

Phase 3

Pulmonary Disease, Chronic Obstructive

Synflorix

Phase 3

Infections, Streptococcal

RSVPreF3 OA vaccine

Phase 3

Respiratory Syncytial Virus Infections

GSK573719

Phase 3

Pulmonary Disease, Chronic Obstructive

PCV-free liquid formulation of GSK's oral live attenuated HRV vaccine

Phase 3

Infections, Rotavirus

Fluarix

Phase 3

Influenza

Boostrix™

Phase 3

Diphtheria

1% diclofenac sodium plus 3% menthol

Phase 3

Pain

GSK580299 (Cervarix)

Phase 3

Infections, Papillomavirus

Meningococcal vaccine GSK 134612

Phase 3

Meningococcal Infection

mepolizumab

Phase 3

Hypereosinophilia

Umeclidinium/Vilanterol 62.5/25 mcg

Phase 3

Pulmonary Disease, Chronic Obstructive

FF

Phase 3

Rhinitis, Allergic, Perennial

GSK investigational FluNG vaccine GSK2186877A, aged lot

Phase 3

Influenza

DTPw-HBV/Hib-MenAC conjugate vaccine

Phase 3

Diphtheria

Pediarix

Phase 3

Poliomyelitis

Measles, Mumps, Rubella and Chickenpox (live vaccine)

Phase 3

Measles

GSK Biologicals' liquid human rotavirus vaccine 444563

Phase 3

Infections, Rotavirus

stannous fluoride

Phase 3

Dentin Sensitivity

PriorixTetra™

Phase 3

Rubella

Mepolizumab IV

Phase 3

Asthma

FF/UMEC/VI

Phase 3

Asthma

HRV PCV-free liquid vaccine

Phase 3

Infections, Rotavirus

GSK investigational vaccine 2186877A

Phase 3

Influenza

Denosumab 70 mg/mL

Phase 3

Fractures, Bone

Infanrix Hexa

Phase 3

Acellular Pertussis

Herpes Zoster Vaccine GSK1437173A

Phase 3

Herpes Zoster

Dostarlimab

Phase 3

Neoplasms, Rectal

Malaria Vaccine 257049

Phase 3

Malaria

GSK580299, GSK Biological's HPV vaccine

Phase 3

Infections, Papillomavirus

HZ/su vaccine GSK1437173A

Phase 3

Herpes Zoster

BW430C (lamotrigine)

Phase 3

Bipolar Disorder

Albiglutide 30 mg weekly

Phase 3

Diabetes Mellitus, Type 2

RSVPreF3 OA investigational vaccine

Phase 3

Respiratory Syncytial Virus Infections

Priorix®

Phase 3

Rubella

Daprodustat

Phase 3

Anaemia

HZ/su

Phase 3

Herpes Zoster

nicotine

Phase 3

Smoking Cessation

Mencevax™ACWY

Phase 3

Infections, Meningococcal

Adacel

Phase 3

Acellular Pertussis

Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (A/Indonesia)

Phase 3

Influenza

Meningitec™

Phase 3

Infections, Meningococcal

Investigational varicella vaccine

Phase 3

Chickenpox

Mencevax ACWY

Phase 3

Infections, Meningococcal

Prophylaxis: Diphtheria, tetanus and pertussis

Phase 3

Acellular Pertussis

rosiglitazone/metformin

Phase 3

Diabetes Mellitus, Type 2

SOC

Phase 3

Asthma

Abciximab

Phase 3

Infarction, Myocardial

GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations)

Phase 3

Influenza

GSK523338

Phase 3

Diabetes Mellitus, Type 2

Rosiglitazone 4 mg

Phase 3

Type 2 Diabetes Mellitus

GSK1605786A

Phase 3

Crohn's Disease

GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A)

Phase 3

Herpes Zoster

Ropinirole prolonged release

Phase 3

Parkinson Disease

Belantamab mafodotin

Phase 3

Multiple Myeloma

Lapatinib

Phase 3

Metastatic Breast Cancer

Influenza vaccine GSK2340272A

Phase 3

Influenza

10 valent pneumococcal conjugate vaccine

Phase 3

Infections, Rotavirus

Infanrix-IPV+Hib™

Phase 3

Acellular Pertussis

Oral Casopitant (GW679769)

Phase 3

Nausea and Vomiting, Chemotherapy-Induced

UMEC/VI Inhalation Powder 62.5/25 mcg via NDPI

Phase 3

Pulmonary Disease, Chronic Obstructive

Tritanrix-HepB/Meningitec conjugate vaccine

Phase 3

Diphtheria

Avandia

Phase 3

Insulin Resistance

Quadrivalent seasonal influenza vaccine(Flu D-QIV) GSK2321138A

Phase 3

Influenza

Lamictal

Phase 3

Epilepsy

Tenofovir disoproxil fumarate (TDF) tablets

Phase 3

Hepatitis B

Rosiglitazone Extended Release 2mg

Phase 3

Alzheimer's Disease

FluLaval™ Quadrivalent

Phase 3

Influenza

Rosiglitazone (BRL49653C)

Phase 3

Diabetes Mellitus, Type 2

diphtheria, tetanus, pertussis & Hib vaccine

Phase 3

Tetanus

Fluoride

Phase 3

Dental Caries

62.5/25mcg

Phase 3

Pulmonary Disease, Chronic Obstructive

Losmapimod 7.5 mg twice daily

Phase 3

Acute Coronary Syndrome

Combined Hepatitis A and B vaccine

Phase 3

Hepatitis B

GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix)

Phase 3

Infections, Meningococcal

Haemophilus influenzae type b- and meningococcal (vaccine)

Phase 3

Haemophilus Influenzae Type b

FLU-QIV

Phase 3

Respiratory Syncytial Virus Infections

glyburide

Phase 3

Diabetes Mellitus, Type 2

Sulfonylurea

Phase 3

Diabetes Mellitus

alosetron

Phase 3

Irritable Colon

Cervarix™

Phase 3

Infections, Papillomavirus

GW406381

Phase 3

Arthritis, Rheumatoid

HBV-MPL vaccine

Phase 3

Hepatitis B

DTPa-HBV-IPV/Hib

Phase 3

Haemophilus Influenzae Type b

Extended-release Bupropion Hydrochloride

Phase 3

Major Depressive Disorder (MDD)

DTPa-HBV-IPV/Hib (Infanrix hexa™)

Phase 3

Hepatitis B

Umeclidinium/vilanterol

Phase 3

Pulmonary Disease, Chronic Obstructive

Lyophilized mepolizumab

Phase 3

Asthma

GSK573719/GW642444 125/25

Phase 3

Pulmonary Disease, Chronic Obstructive

Umeclidinium bromide 62.5mcg

Phase 3

Pulmonary Disease, Chronic Obstructive

Live attenuated human rotavirus vaccine

Phase 3

Rotavirus Gastroenteritis

paracetamol + caffeine

Phase 3

Common Cold

HZ/su vaccine

Phase 3

Respiratory Syncytial Viruses

VI

Phase 3

Pulmonary Disease, Chronic Obstructive

Tiotropium

Phase 3

Pulmonary Disease, Chronic Obstructive

GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine

Phase 3

Haemophilus Influenzae Type b

GSK Bio's influenza vaccine GSK2186877A

Phase 3

Influenza

GSK2269557 DPI

Phase 2

Pulmonary Disease, Chronic Obstructive

Adjuvanted Hepatitis B surface antigen (HBsAg) candidate vaccine GSK2231392A.

Phase 2

Hepatitis B

Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose

Phase 2

Salmonella Infections

Aprepitant

Phase 2

Nausea and Vomiting

RTS,S/AS01E

Phase 2

Malaria

GSK2982772

Phase 2

Psoriasis

10mg atorvastatin

Phase 2

Dyslipidaemias

SB-485232

Phase 2

Melanoma

Investigational MMRV(H)NS vaccine

Phase 2

Measles; Mumps; Rubella; Chickenpox

16448

Phase 2

Premature Ejaculation

Sodium bicarbonate and sodium fluoride

Phase 2

Oral Hygiene

5% KNO3 / 0.2542% NaF dentifrice with 0.5% spherical silica

Phase 2

Oral Hygiene

1278863A

Phase 2

Kidney Disease

FLU-Q-PAN H7N9 Formulation 1

Phase 2

Influenza, Human

Pandemic influenza vaccine (GSK1562902A) (adjuvanted or not)

Phase 2

Influenza

salmeterol 50mcg

Phase 2

Asthma

GBS Trivalent Vaccine

Phase 2

Bacterial Infection Due to Streptococcus, Group B

GSK malaria vaccine 257049 Vaccine

Phase 2

Malaria

GW869682

Phase 2

Obesity

A/turkey H5N1 vaccine

Phase 2

Influenza

GSK364735

Phase 2

Infection, Human Immunodeficiency Virus

GSK1521498

Phase 2

Obesity

Belrestotug

Phase 2

Neoplasms, Head and Neck

GW810781

Phase 2

HIV Infections

Feladilimab

Phase 2

Multiple Myeloma

SB424323

Phase 2

Fibrillation, Atrial

GSK233705B

Phase 2

Pulmonary Disease, Chronic Obstructive

GSK835726 10mg

Phase 2

Rhinitis, Allergic, Seasonal

MenHibrix (Hib-MenCY-TT)

Phase 2

Neisseria Meningitidis

F2C22C/DL001Z

Phase 2

Influenza, Human

Varilrix (inactivated varicella vaccine)

Phase 2

Varicella

GW876008

Phase 2

Irritable Colon

Conjugated meningococcal ACWY-TT (vaccine)

Phase 2

Infections, Meningococcal

GSK256073 1mg

Phase 2

Diabetes Mellitus, Type 2

GSK2190915

Phase 2

Asthma

Ofatumumab

Phase 2

Lymphoma, Large-Cell, Diffuse

rhEPO

Phase 2

Anaemia

GSK2402968

Phase 2

Muscular Dystrophies

Priorix-Tetra (combined measles-mumps-rubella-varicella vaccine)

Phase 2

Measles

GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A)

Phase 2

Virus Diseases

Chlorproguanil-dapsone-artesunate (CDA)

Phase 2

Malaria

Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab)

Phase 2

Lymphoma, Non-Hodgkin

Prevenar 13

Phase 2

Acellular Pertussis

GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049

Phase 2

Malaria

SB-480848 40 mg

Phase 2

Atherosclerosis

GSK2269557

Phase 2

Pulmonary Disease, Chronic Obstructive

Otilimab

Phase 2

Severe Acute Respiratory Syndrome

Paracetamol hot drink

Phase 2

Common Cold

GSK2798745 solution

Phase 2

Oedema, Pulmonary

Iodine I 131 Tositumomab

Phase 2

Non-Hodgkin's Lymphoma

meningococcal ACWY (vaccine)

Phase 2

Infections, Meningococcal

ropinirole controlled release (CR)-RLS

Phase 2

Restless Legs Syndrome

GSK2202083A vaccine

Phase 2

Tetanus

PegIFN

Phase 2

Hepatitis B

GSK1292263

Phase 2

Diabetes Mellitus, Type 2

Nirogacestat

Phase 2

Multiple Myeloma

GSK2894512 1% Cream

Phase 2

Psoriasis

Albiglutide (GSK716155) or exenatide

Phase 2

Diabetes Mellitus, Type 2

retapamulin

Phase 2

Infections, Bacterial

GSK2894512 0.5% Cream

Phase 2

Dermatitis, Atopic

FP

Phase 2

Rhinitis

Lapatinib and Capecitabine

Phase 2

Neoplasms, Gastrointestinal Tract

HBV-MPL vaccine (208129)

Phase 2

Hepatitis B

Dose 1 GSK2586881

Phase 2

Lung Injury, Acute

Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted

Phase 2

Influenza

HIV vaccine 732461

Phase 2

AIDS

GW856553

Phase 2

Arthritis, Rheumatoid

Flu mRNA (Formulation B1)

Phase 2

Influenza, Human

Thiomersal-free FluAS25 adjuvanted vaccine (GSK576389A)

Phase 2

Influenza

GSK's candidate Mycobacterium tuberculosis vaccine 692342

Phase 2

Tuberculosis

GSK2036874A vaccine

Phase 2

Haemophilus Influenzae Type b

Cervarix vaccine

Phase 2

Infections, Papillomavirus

Infanrix hexa Vaccine

Phase 2

Acellular Pertussis

GW493838

Phase 2

Neuropathic Pain

Meningococcal vaccine 134612

Phase 2

Infections, Meningococcal

NTHi-10-AS01E

Phase 2

Respiratory Disorders

Menactra®

Phase 2

Infections, Meningococcal

GSK835726 (10mg)

Phase 2

Rhinitis, Allergic, Seasonal

Influenza Vaccine GSK1247446A

Phase 2

Influenza

tositumomab and iodine I-131 tositumomab

Phase 2

Lymphoma, Non-Hodgkin

GSK2269557 100 MCG

Phase 2

Pulmonary Disease, Chronic Obstructive

pazopanib and pemetrexed

Phase 2

Lung Cancer, Non-Small Cell

Live attenuated rotavirus vaccine

Phase 2

Infections, Rotavirus

Nicotine lower dose

Phase 2

Smoking

GSK2118436

Phase 2

Melanoma and Brain Metastases

Adjuvanted RSVPreF3 vaccine

Phase 2

Respiratory Syncytial Virus Infections

Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141

Phase 2

Prophylaxis Herpes Simplex

FF/Vilanterol (VI; GW642444M)

Phase 2

Asthma

GSK2982772 60 mg

Phase 2

Arthritis, Rheumatoid

GSK5460025

Phase 2

Neoplasms, Colorectal

letetresgene autoleucel (GSK3377794)

Phase 2

Neoplasms

RTS,S/AS01E (SB257049)

Phase 2

Malaria

GSK221149A

Phase 2

Obstetric Labour, Premature

GSK4524101

Phase 2

Neoplasms

GSK716155 subcutaneous injections

Phase 2

Diabetes Mellitus, Type 2

GSK Biologicals' HIV vaccine (732461)

Phase 2

AIDS

Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A).

Phase 2

Influenza

GW842166

Phase 2

Osteoarthritis, Knee

Zalcitabine

Phase 2

HIV Infections

GSK2336805 40 mg

Phase 2

Hepatitis C, Chronic

Mepolizumab 750

Phase 2

Asthma

GSK163090 1 mg

Phase 2

Depressive Disorder

HPV 16/18 L1 AS04

Phase 2

Infections, Papillomavirus

SB-480848

Phase 2

Atherosclerosis

vestipitant

Phase 2

Depressive Disorder and Anxiety Disorders

pazopanib (GW786034)

Phase 2

Neoplasms, Uterine Cervix

SB497115

Phase 2

Purpura, Thrombocytopaenic, Idiopathic

rosiglitazone XR

Phase 2

Arthritis, Rheumatoid

Talnetant

Phase 2

Schizophrenia

GW642444

Phase 2

Pulmonary Disease, Chronic Obstructive

GSK4532990

Phase 2

Non-alcoholic Fatty Liver Disease

FP 100

Phase 2

Asthma

adjuvanted influenza vaccine

Phase 2

Influenza

Pneumococcal vaccine GSK2189242A

Phase 2

Infections, Streptococcal

RSV vaccine GSK3003891A

Phase 2

Respiratory Syncytial Virus Infections

Losmapimod tablets

Phase 2

Pulmonary Disease, Chronic Obstructive

Bepirovirsen

Phase 2

Hepatitis B

Human Rotavirus Vaccine - two different formulations

Phase 2

Infections, Rotavirus

GSK962040 25 mg

Phase 2

Gastroparesis

Carbomer 980 (1146A)

Phase 2

Common Cold

GSK Biologicals' investigational TB vaccine (GSK692342)

Phase 2

Tuberculosis

RSVPreF3 OA investigational vaccine (GSK3844766A)

Phase 2

Respiratory Syncytial Virus Infections

RSV MAT 60 µg

Phase 2

Respiratory Syncytial Virus Infections

HPV9 High formulation

Phase 2

Cervical Intraepithelial Neoplasia

DTPa-HBV-IPV/Hib (Infanrix-hexa™)

Phase 2

Hepatitis B

Lapatinib oral tablets

Phase 2

Neoplasms, Breast

GSK3228836

Phase 2

Hepatitis B

RTS,S/AS01E vaccine

Phase 2

Malaria

chlorambucil, tablets

Phase 2

Leukaemia, Lymphoblastic

Chloroquine 600mg

Phase 2

Malaria, Vivax

MenC-TT

Phase 2

Infections, Meningococcal

Nelfinavir mesylate

Phase 2

HIV Infections

GSK372475

Phase 2

Depressive Disorder

SERETIDE Rotacaps

Phase 2

Asthma

SB683699

Phase 2

Multiple Sclerosis, Relapsing-Remitting

SB705498 400 mg

Phase 2

Toothache

GSK Biologicals' investigational vaccine GSK1562902A

Phase 2

Influenza

oral nicotine

Phase 2

Smoking Dependence

Rotavirus

Phase 2

Infections, Rotavirus

FFNS 110 mcg QD

Phase 2

Sinusitis, Acute

Topotecan/Docetaxel combination

Phase 2

Lung Cancer, Non-Small Cell

nelarabine

Phase 2

Leukemia

UMEC

Phase 2

Asthma

GSK2197870A

Phase 2

Neisseria Meningitidis

Lapatinib in combination with weekly paclitaxel

Phase 2

Neoplasms, Breast

GW685698X 200mcg,GW685698X 200mcg and 400mcg

Phase 2

Asthma

Losmapimod

Phase 2

Glomerulosclerosis, Focal Segmental

Pneumococcal vaccine GSK2189242A (formulation 1)

Phase 2

Infections, Streptococcal

SB-773812

Phase 2

Schizophrenia

Dose 4 QD

Phase 2

Asthma

Tositumomab and Iodine I 131 Tositumomab

Phase 2

Lymphoma, Non-Hodgkin

Unconjugated belantamab antibody

Phase 2

Multiple Myeloma

Stavudine

Phase 2

HIV Infections

Firategrast 150 mg

Phase 2

Multiple Sclerosis

683699

Phase 2

Crohn's Disease

vinorelbine tartrate

Phase 2

Lung Cancer

Batefenterol

Phase 2

Pulmonary Disease, Chronic Obstructive

cycolophosphamide, vacristine, and pednisone (CVP) x6 cycles followed by tositumomab and iodine I 131 tositumomab.

Phase 2

Lymphoma, Non-Hodgkin

Ritonavir

Phase 2

HIV Infections

0.12% chlorhexidine mouthrinse

Phase 2

Healthy Subjects

Iodine I 131 Tositumomab Therapeutic Regimen

Phase 2

Lymphoma, Non-Hodgkin

Intravenous GR270773- Phospholipid Emulsion

Phase 2

Sepsis

Ambrisentan

Phase 2

Hypertension, Pulmonary

GSK2110183

Phase 2

Langerhans Cell Histiocytosis

SB-742457

Phase 2

Alzheimer's Disease

GSK2245035

Phase 2

Asthma and Rhinitis

Prophylaxis: Diphtheria, tetanus, pertussis, poliovirus type 1, type 2 and type 3

Phase 2

Diphtheria

Herpes Zoster vaccine GSK1437173A Low Dose

Phase 2

Herpes Zoster

SRA737, gemcitabine, cisplatin

Phase 2

Advanced Solid Tumors

Rotavirus (vaccine)

Phase 2

Rotavirus Infections

GSK2330672

Phase 2

Cholestasis, Intrahepatic

NC-758 (Anti amyloidotic [Aß] agent)

Phase 2

Stroke

GW870086X

Phase 2

Asthma

GSK Biologicals' influenza vaccine GSK1557482A

Phase 2

Influenza

GSK Biologicals' investigational TB vaccine GSK 692342

Phase 2

Tuberculosis

SB-705498

Phase 2

Rhinitis

GSK573179

Phase 2

Pulmonary Disease, Chronic Obstructive

GW823093 15mg

Phase 2

Diabetes Mellitus, Type 2

Talarozole

Phase 2

Psoriasis

Efavirenz

Phase 2

HIV Infections

Non-adjuvanted HSV formulation 1

Phase 2

Herpes Simplex

Radafaxine

Phase 2

Major Depressive Disorder (MDD)

IONIS-HBVRx

Phase 2

Hepatitis B

PNT2258

Phase 2

Lymphoma, Non-Hodgkin's

GSK2340274A

Phase 2

Influenza

RTS,S/AS02A

Phase 2

Malaria

Tucaresol tablets 25 mg

Phase 2

HIV Infection

Pandemic influenza vaccine GSK2340272A

Phase 2

Influenza

HRV vaccine

Phase 2

Infections, Rotavirus

GW501516 oral tablets

Phase 2

Dyslipidaemias

Meningococcal (vaccine)

Phase 2

Infections, Meningococcal

GSK256066

Phase 2

Asthma

GSK's investigational vaccine 692342

Phase 2

Tuberculosis

GSK Biologicals' Candidate Tuberculosis (TB) Vaccine (692342)

Phase 2

Tuberculosis (TB)

GSK2881078

Phase 2

Cachexia

Albaconazole 100mg

Phase 2

Onychomycosis

Tositumomab 450 mg

Phase 2

Lymphoma, Non-Hodgkin

GSK962040 (5 mg tablet)

Phase 2

Gastroparesis

GW679769

Phase 2

Depressive Disorder, Major

CV0701 mRNA COVID-19 Vaccine (Low dose)

Phase 2

SARS-CoV-2

Nanomilled testosterone

Phase 2

Hypogonadism

Flu Pandemic mRNA_Dose level 1

Phase 2

Influenza, Human

GW677954

Phase 2

Metabolic Syndrome X

Benzoyl peroxide gel

Phase 2

Acne Vulgaris

Candidate Influenza Vaccine GSK1247446A - 2 different formulations

Phase 2

Influenza

GW685698/GW642444

Phase 2

Pulmonary Disease, Chronic Obstructive

MMB

Phase 2

Primary Myelofibrosis (PMF)

GW786034

Phase 2

Carcinoma, Renal Cell

Zanamivir

Phase 2

Influenza, Human

NC-503 (eprodisate disodium)

Phase 2

Diabetes Mellitus, Type 2

GSK1363089 (foretinib)

Phase 2

Neoplasms, Head and Neck

SB480848 40mg EC Tablet

Phase 2

Atherosclerosis

SRT2104

Phase 2

Diabetes Mellitus, Type 2

Run In Medication

Phase 2

Nasal Polyps

GSK3196165

Phase 2

Arthritis, Rheumatoid

SB681323

Phase 2

Pain, Neuropathic

SRA737

Phase 2

Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)

RSV Vaccine (GSK3003891A) formulation 1

Phase 2

Respiratory Syncytial Virus Infections

GSK189075

Phase 2

Diabetes Mellitus, Type 2

NTHi Mcat investigational vaccine (GSK3277511A)

Phase 2

Respiratory Disorders

CYT387

Phase 2

Primary Myelofibrosis

GSK Biologicals HIV Vaccine 732462

Phase 2

AIDS

GSK249320

Phase 2

Ischaemic Attack, Transient

eltrombopag

Phase 2

Purpura, Thrombocytopaenic, Idiopathic

HPV 16/18 VLP AS04

Phase 2

Infections, Papillomavirus

GW274150

Phase 2

Migraine Disorders

GSK5784283

Phase 2

Asthma

SB-681323 Intravenous 3mg

Phase 2

Lung Injury, Acute

GSK Biologicals' GSK2340274A (two different formulations)

Phase 2

Influenza

Cobolimab

Phase 2

Melanoma

GSK239512

Phase 2

Schizophrenia

Tritanrix™ HB+Hib

Phase 2

Tuberculosis

foretinib (formerly GSK1363089 or XL880)

Phase 2

Carcinoma, Renal Cell

GW766944

Phase 2

Asthma

Luspatercept

Phase 2

Primary Myelofibrosis

GS856553

Phase 2

Pain, Neuropathic

albiglutide (GSK716155)

Phase 2

Diabetes Mellitus, Type 2

GSK4527226

Phase 2

Alzheimer's Disease

Hepatitis B

2 drugs in this indication

cough

2 drugs in this indication

Pulmonary Disease, Chronic Obstructive

2 drugs in this indication

Acute Coronary Syndrome

1 drug in this indication

Malaria

1 drug in this indication

refractory chronic cough

1 drug in this indication

chronic cough

1 drug in this indication

dementia prevention

1 drug in this indication

chronic cough (RCC), IBS

1 drug in this indication

colorectal cancer, pancreatic cancer, lung cancer

1 drug in this indication

solid tumours

1 drug in this indication

NSCLC

1 drug in this indication

ROS1-positive lung cancer

1 drug in this indication

lung cancer

1 drug in this indication

Dental Caries

1 drug in this indication

ROS1-positive non-small cell lung cancer

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

📑
Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
→
Catalyst Verdict

Full breakdown — the signals behind the verdict

Market-Implied Move
Regulatory Approvals

Frequently asked questions

What is in GSK plc's drug pipeline?→

CatalystAlert tracks 503 drug candidates in GSK plc's (GSK) pipeline across Phase 3, Phase 2. Its lead program is Daprodustat small (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is GSK plc's next FDA catalyst?→

GSK plc's (GSK) next tracked catalyst is a Phase 2 expected September 1, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track GSK biotech catalysts?→

Add GSK to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow GSK plc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply